UK markets closed
NIKKEI 225
38,073.98 -128.39 (-0.34%) HANG SENG
18,537.81 +223.95 (+1.22%) CRUDE OIL
79.27 +0.28 (+0.35%) GOLD FUTURES
2,337.70 +15.40 (+0.66%) DOW
39,256.99 +200.60 (+0.51%) Bitcoin GBP
49,542.93 -316.91 (-0.64%)
Pacira BioSciences Inc (82P.MU)
Munich - Munich Delayed price. Currency in EUR
Add to watchlist
As of 08:08AM CEST. Market open.
| Previous close | 24.80 |
| Open | 26.00 |
| Bid | 27.60 x N/A |
| Ask | 27.80 x N/A |
| Day's range | 26.00 - 26.00 |
| 52-week range | 24.00 - 39.00 |
| Volume | |
| Avg. volume | 0 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Pacira (PCRX) Q1 Earnings Miss, Exparel Sales Drive Revenues
Pacira (PCRX) reports first-quarter 2024 results, wherein earnings miss but revenues beat estimates, driven by Exparel sales.
- Insider Monkey
Pacira BioSciences, Inc. (NASDAQ:PCRX) Q1 2024 Earnings Call Transcript
Pacira BioSciences, Inc. (NASDAQ:PCRX) Q1 2024 Earnings Call Transcript May 7, 2024 Pacira BioSciences, Inc. misses on earnings expectations. Reported EPS is $0.62 EPS, expectations were $0.64. PCRX isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Thank you for standing […]
- GuruFocus.com
Pacira BioSciences Inc (PCRX) (Q1 2024) Earnings Call Transcript Highlights: Strategic Growth ...
Explore key insights from Pacira BioSciences' Q1 2024 earnings, featuring sales growth, strategic initiatives, and future outlook.
© 2024 Yahoo. All rights reserved.